Inderal

Propranolol, the active ingredient in Inderal, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, chest pain, irregular heart rhythms, migraine prevention and several other cardiovascular and neurological conditions.

GNH USA supplies Inderal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inderal is a non‑selective beta‑adrenergic antagonist used across several cardiovascular and neurological disease pathways. - Hypertension: lowers elevated blood pressure by reducing cardiac output and renin release. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Cardiac arrhythmias: stabilises abnormal heart rhythms by slowing conduction through the AV node. - Migraine prophylaxis: reduces frequency and severity of migraine attacks through vascular modulation.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold hands and feet - Nausea or mild stomach upset - Sleep disturbances or vivid dreams - Bradycardia (slow heart rate)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm or severe asthma exacerbation - Allergic reactions such as rash, swelling, or anaphylaxis - Depression or mood changes - Worsening of heart failure

Before initiating therapy, clinicians should assess patient‑specific factors and monitor for adverse outcomes. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Cardiac function review: evaluate for underlying heart block or severe bradycardia. - Respiratory caution: avoid in uncontrolled asthma or severe chronic obstructive pulmonary disease. - Diabetes management: monitor glucose as beta‑blockade may mask hypoglycaemia symptoms. - Renal/hepatic impairment: dose adjustment may be required in reduced clearance. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Propranolol may interact with several medicines, altering efficacy or safety. Major Interactions (Avoid): - Asthma or COPD medications: non‑selective blockade can precipitate bronchospasm. - Severe bradycardia or AV‑block agents: additive slowing of cardiac conduction. - Certain anti‑arrhythmic drugs (e.g., digoxin): increased risk of heart block. Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycaemics: may mask hypoglycaemia signs. - Calcium‑channel blockers (verapamil, diltiazem): can enhance bradycardia and hypotension. - Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome when combined with other serotonergic agents.